Trials that use: Logistic regression
New to this method? Read the tutorial →
5,900 results
- SARS-CoV-2 Human Challenge Characterisation Study: Complete Statistical AnalysisIndependent statistical analysis of SARS-CoV-2 Human Challenge Characterisation Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04865237).
- SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation: Complete Statistical AnalysisIndependent statistical analysis of SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04631705).
- Satisfaction in Patients Receiving the PegIntron Pen Plus Rebetol for Hepatitis C (Study P04244)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of Satisfaction in Patients Receiving the PegIntron Pen Plus Rebetol for Hepatitis C (Study P04244)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SayLipIndependent statistical analysis of Study to Evaluate the Effectiveness, Safety and Long Term Safety of Saypha® FILLER Lidocaine for Lip Augmentation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SBRTvsTACEIndependent statistical analysis of Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SCALE-UP Utah II: Community-Academic Partnership to Address COVID-19 Conversational Agent Study: Complete Statistical AnalysisIndependent statistical analysis of SCALE-UP Utah II: Community-Academic Partnership to Address COVID-19 Conversational Agent Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Testing Among Utah Community Health Centers: Complete Statistical AnalysisIndependent statistical analysis of SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Testing Among Utah Community Health Centers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SCALPIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp: primary endpoint results, effect…
- SCANREP: Reliability of 3D Lower Limb Scanning: Complete Statistical AnalysisIndependent statistical analysis of SCANREP: Reliability of 3D Lower Limb Scanning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04032041).
- SCD PED-02Independent statistical analysis of A Multi-Center Study of a SCD for Immunomodulatory Dysregulation in Pediatric AKI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SCENT2Independent statistical analysis of Smell in Covid-19 and Efficacy of Nasal Theophylline: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04789499).
- SCH 54031 PEG12000 Interferon Alfa-2b (PEG Intron, MK-4031) vs. INTRON®A (SCH 30500, MK-2958) as Adjuvant Therapy for Melanoma (C98-135, MK-4031-002): Complete Statistical AnalysisIndependent statistical analysis of SCH 54031 PEG12000 Interferon Alfa-2b (PEG Intron, MK-4031) vs. INTRON®A (SCH 30500, MK-2958) as Adjuvant Therapy for Melanoma (C98-135, MK-4031-002): primary endpoint results, effect estimate with confidence interval,…
- SCITMOIndependent statistical analysis of Subcutaneous Immunotherapy for Mouse in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02532179).
- SCNSL1Independent statistical analysis of High-dose Sequential Chemoimmunotherapy for B-cell Lymphomas With Central Nervous System Involvement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SCOTIndependent statistical analysis of Scleroderma: Cyclophosphamide or Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00114530).
- SCS-90Independent statistical analysis of Spinal Cord Stimulation for Restoration of Function in Lower-Limb Amputees, 90-Day: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency: Complete Statistical AnalysisIndependent statistical analysis of Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SDOHIndependent statistical analysis of Social Determinants of Health Screening and Interventions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03661359).
- SDTTIndependent statistical analysis of Assessment of Laryngopharyngeal Sensation in Adductor Spasmodic Dysphonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05158179).
- SEARCHIndependent statistical analysis of Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup: Complete Statistical AnalysisIndependent statistical analysis of Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup:…
- SedLine Engineering Data Collection Study in Pediatric Patients Undergoing General Anesthesia or Sedation: Complete Statistical AnalysisIndependent statistical analysis of SedLine Engineering Data Collection Study in Pediatric Patients Undergoing General Anesthesia or Sedation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SEEK: Dissemination and Implementation: Complete Statistical AnalysisIndependent statistical analysis of SEEK: Dissemination and Implementation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03642327).
- SEJIndependent statistical analysis of Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03047473).
- SELECT-3Independent statistical analysis of Assess Safety & Efficacy of Selumetinib When Given in Combination With Standard First Line Treatment for Advanced Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence…
- SELECT-EARLYIndependent statistical analysis of A Study to Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have Not Previously Taken Methotrexate: primary endpoint results, effect estimate…
- SELECT2Independent statistical analysis of SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD: Complete Statistical AnalysisIndependent statistical analysis of Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Myelodysplastic Syndromes: Complete Statistical AnalysisIndependent statistical analysis of Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SELECTSUNRISEIndependent statistical analysis of A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and…
- Self-System Therapy for Older Adults With Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Self-System Therapy for Older Adults With Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04057196).
- Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma: Complete Statistical AnalysisIndependent statistical analysis of Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SENECAIndependent statistical analysis of Stem Cell Injection in Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02509156).
- Sensory Effects of Rapidly-Changing Magnetic Fields: Complete Statistical AnalysisIndependent statistical analysis of Sensory Effects of Rapidly-Changing Magnetic Fields: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01632800).
- Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.: Complete Statistical AnalysisIndependent statistical analysis of Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.: primary endpoint results, effect…
- Sequential and Hybrid Therapies for H Pylori Infection: Complete Statistical AnalysisIndependent statistical analysis of Sequential and Hybrid Therapies for H Pylori Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01085786).
- Sequential Vaccinations in Prostate Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Sequential Vaccinations in Prostate Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00060528).
- SERENEIndependent statistical analysis of Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy: primary endpoint results, effect…
- Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC): Complete Statistical AnalysisIndependent statistical analysis of Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04508725).
- Serious Game-based Interventions in Patients With Mild Cognitive Impairment Outside the Clinic: Complete Statistical AnalysisIndependent statistical analysis of Serious Game-based Interventions in Patients With Mild Cognitive Impairment Outside the Clinic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults: Complete Statistical AnalysisIndependent statistical analysis of Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05972733).
- Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery: Complete Statistical AnalysisIndependent statistical analysis of Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Serum Levels of Bupivacaine in Autotransfusion Drains Following Total Joint Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Serum Levels of Bupivacaine in Autotransfusion Drains Following Total Joint Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Severe Renal Disease Study in Fabry Patients Treated With Fabrazyme: Complete Statistical AnalysisIndependent statistical analysis of Severe Renal Disease Study in Fabry Patients Treated With Fabrazyme: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00837824).
- SFA ISRIndependent statistical analysis of Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SGI-110Independent statistical analysis of SGI-110 in Combination With Carboplatin in Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01696032).
- SH-DS01 on Fecal Metagenomic Stability: Complete Statistical AnalysisIndependent statistical analysis of SH-DS01 on Fecal Metagenomic Stability: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04598295).